Dr C Mallikarjuna Rao
Professor
Date of Joining: 13.12.1986
Department of Pharmacology
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
- engages in department affairs.
- Contributes to department activities, including planning and development.
- Is involved in the academic and research activities at the department of Pharmacology.
C Mallikarjuna Rao is Professor at the Department of Pharmacology at 沙巴体育 College of Pharmaceutical Sciences.
He:
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Advances in Molecular and Cellular Pharmacology (Theory) | I year MPharm |
| Dissertation work | MPharm part-II |
| Pharmacology-II | Fourth BPharm |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| PhD | Wound Healing | Mangalore University | 1990 |
| MPharm | Pharmacology | College of Pharmaceutical Sciences 沙巴体育 | 1985 |
| BPharm | College of Pharmaceutical Sciences 沙巴体育 | 1983 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| 沙巴体育 College of Pharmaceutical Sciences | Professor | 2024 March till date | |
| 沙巴体育 College of Pharmaceutical Sciences | Principal | 2013-2024 (February) | |
| 沙巴体育 College of Pharmaceutical Sciences | Vice-Principal | 2009 | |
| Department of Pharmacology, MCOPS | Head | 2004 | |
| Department of Pharmacology, MCOPS | Professor | 2002 | |
| Department of Pharmacology, MCOPS | Additional Professor | 2001 - 2002 | |
| Department of Pharmacology, MCOPS | Associate Professor | 1992 - 2001 | |
| Department of Pharmacology, MCOPS | Reader | 1990 - 1992 | |
| Department of Pharmacology, MCOPS | Assistant Professor | 1987 - 1990 | |
| Department of Pharmacology, MCOPS | Lecturer | 1986 - 1987 | |
| NGSM College of Pharmacy, Nitte 1985-1986 | Lecturer | 1 year |
Development and evaluation of liposomal carrier system of hepatoprotective agents to target the liver
2013-01-08
Funded by AICTE under MODROBS scheme [9-126/RIFD/MODROB/BOR/Policy-1/2013-2014], New Delhi
Evaluation of Glycosmis pentaphylla (Retz) DC for histone deacetylase Inhibition
2013-10-07
Funded by AICTE under RPS scheme (Grant Ref.No 20/AICTE/RIFID/RPS/(Policy-1) 64/2013-14/), New Delhi (Principal Investigator)
Development of novel quercetin analogues intended for selective HDAC-8 inhibition as beneficial anti-cancer agents
2013-16-08
Funded by DST under SERB scheme (Grant Ref No SERB/F/31314/2013-14) New Delhi. (Principal Investigator)
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Physiology and Pharmacology of inflammation and tissue repair, Screening the molecules for anticancer activity, Role of oxidative stress and free radicals in DNA damage
Area of Expertise
Pharmacology of wound healing and role of antioxidants on healing status
Area of 沙巴体育
Screening the molecules for their efficacy against diabetes and dyslipidemia
Professional Affiliations & Contributions
- MAHE Good Teacher Award MCOPS, 2003-2004.
- MAHE Good Teacher Award MCOPS, 2001-2002.
- Distinguished 沙巴体育 Award MCOPS, 沙巴体育 University, Dec 17, 1995.
- Dr TMA Pai 沙巴体育 Gold Medal for publishing the best research paper in the year 1988.
- Life member of Indian Pharmacological Society.
- Life member of Indian Pharmaceutical Association.
- Life member of Association of Pharmaceutical Teachers of India.
- Life member of The Society for Wound care and 沙巴体育.
- Life member of Association of Community Pharmacist of India.
An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells
Reddy ND Shoja MH Biswas S Nayak PG Kumar N Rao CM
2016, Chemico-Biological Interaction
In vitro mechanistic and in vivo anti-tumor studies of Glycosmis pentaphylla (Retz) DC against breast cancer
Shoja MH Reddy ND Nayak PG Biswas S Srinivasan KK Rao CM
2016, Journal of Ethnopharmacology
Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in rats
K Nandakumar Suhaj A ManuMK Unnikrishnan MK Vijayanarayana K Rao CM
2016, Journal of Clinical Pharmacy and Therapeutics
Validation of a sensitive and robust reversed phase-HPLC method of determination of temozolamide
Attari Z Kumar L Rao CM Koteshwara KB
2016, Latin American Journal of Pharmacy
Role of the drug transporter ABCC3 in breast cancer chemoresistance.
Balaji SA Udupa N Chamallamudi MR Gupa V Rangarajan A
2016, Plos One
The enriched fraction of Elephantopus scaber Triggers apoptosis and inhibits multi-drug resistance transporters in human epithelial cancer cells
Asmy Appadath Beeran Naseer Maliyakkal Chamallamudi Mallikarjuna Rao Nayanabhirama Udupa
Pharmacognosy Magazine 2015, Vol 11 issue 42
Modulatory Role of Simvastatin against Aluminium Chloride-Induced Behavioural and Biochemical Changes in Rats
Madhavan Nampoothiri Jessy John Nitesh Kumar Jayesh Mudgal Gopalan Kutty Nampurath Mallikarjuna Rao Chamallamudi
Behavioural Neurology, Aricle ID 210169, 9 Pages [2015]
Sesamol, a lipid lowering agent, ameliorates aluminium chloride induced behavioral and biochemical alterations in rats
Jessy John Madhavan Nampoothiri Nitesh Kumar Jayesh Mudgal Gopalan Kutty Nampurath Mallikarjuna Rao Chamallamudi
Pharmacognosy Magazine April-June 2015, Vol 11
In vitro and in vivo evaluation of novel cinnamyl sulfonamide hydroxamate derivative against colon adenocarcinoma
Neetinkumar D. Reddy M.H. Shoja B.S. Jayashree Pawan G. Nayak Nitesh Kumar V. Ganga Prasad K. Sreedhara R. Pai C. Mallikarjuna Rao
Chemico-Biological Interactions 233 (2015) 81-94